Improving access to opioid use disorder treatment for Black and Hispanic individuals
Improving racial equity in opioid use disorder treatment in Medicaid
This study is looking at how Black and Hispanic people can get better access to medications for treating opioid use disorder through Medicaid, and it aims to find ways to make these services fairer and more effective for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10877774 on NIH RePORTER |
What this research studies
This research investigates the disparities in access to medications for opioid use disorder (MOUD) among Black and Hispanic individuals, particularly in the context of Medicaid. It aims to identify effective policy changes that Medicaid can implement to improve equity in the delivery of MOUD and overdose prevention services. By analyzing data from the Medicaid Outcomes Distributed Research Network (MODRN), the research will explore various strategies, such as altering financial incentives for providers and enhancing support for minority-serving providers. The goal is to develop actionable recommendations that can help reduce racial and ethnic disparities in opioid treatment access.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black and Hispanic individuals who are experiencing opioid use disorder and are eligible for Medicaid.
Not a fit: Patients who do not have Medicaid coverage or those who do not identify as Black or Hispanic may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to life-saving opioid use disorder treatments for marginalized communities.
How similar studies have performed: Previous research has shown that addressing systemic inequities in healthcare can lead to improved outcomes, suggesting that this approach has the potential for success.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Donohue, Julie Marie — University of Pittsburgh at Pittsburgh
- Study coordinator: Donohue, Julie Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.